CN113754762B - 一种抗Cry3Bb蛋白单域重链抗体及其应用 - Google Patents
一种抗Cry3Bb蛋白单域重链抗体及其应用 Download PDFInfo
- Publication number
- CN113754762B CN113754762B CN202111086088.XA CN202111086088A CN113754762B CN 113754762 B CN113754762 B CN 113754762B CN 202111086088 A CN202111086088 A CN 202111086088A CN 113754762 B CN113754762 B CN 113754762B
- Authority
- CN
- China
- Prior art keywords
- chain antibody
- heavy chain
- domain heavy
- cry3bb
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract description 37
- 102000004169 proteins and genes Human genes 0.000 title abstract description 37
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 239000013604 expression vector Substances 0.000 claims description 6
- 238000003259 recombinant expression Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 9
- 238000001514 detection method Methods 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 3
- 230000001900 immune effect Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 21
- 241001416177 Vicugna pacos Species 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 description 7
- 101000800023 Homo sapiens 4F2 cell-surface antigen heavy chain Proteins 0.000 description 7
- 238000002823 phage display Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000003032 molecular docking Methods 0.000 description 4
- 238000004091 panning Methods 0.000 description 4
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 3
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000006687 ag medium Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 244000037671 genetically modified crops Species 0.000 description 3
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 2
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 2
- NABSCJGZKWSNHX-RCWTZXSCSA-N Arg-Arg-Thr Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NABSCJGZKWSNHX-RCWTZXSCSA-N 0.000 description 2
- OGZBJJLRKQZRHL-KJEVXHAQSA-N Arg-Thr-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OGZBJJLRKQZRHL-KJEVXHAQSA-N 0.000 description 2
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 2
- FAEIQWHBRBWUBN-FXQIFTODSA-N Asp-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N)CN=C(N)N FAEIQWHBRBWUBN-FXQIFTODSA-N 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- ZFBBMCKQSNJZSN-AUTRQRHGSA-N Gln-Val-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZFBBMCKQSNJZSN-AUTRQRHGSA-N 0.000 description 2
- CLODWIOAKCSBAN-BQBZGAKWSA-N Gly-Arg-Asp Chemical compound NC(N)=NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O CLODWIOAKCSBAN-BQBZGAKWSA-N 0.000 description 2
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 2
- ZTLGVASZOIKNIX-DCAQKATOSA-N Leu-Gln-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZTLGVASZOIKNIX-DCAQKATOSA-N 0.000 description 2
- LOLUPZNNADDTAA-AVGNSLFASA-N Leu-Gln-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LOLUPZNNADDTAA-AVGNSLFASA-N 0.000 description 2
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 2
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 2
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 2
- QVTDVTONTRSQMF-WDCWCFNPSA-N Lys-Thr-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CCCCN QVTDVTONTRSQMF-WDCWCFNPSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 2
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 2
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 2
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 2
- VDUJEEQMRQCLHB-YTQUADARSA-N Trp-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N)C(=O)O VDUJEEQMRQCLHB-YTQUADARSA-N 0.000 description 2
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- LGQPPBQRUBVTIF-JBDRJPRFSA-N Ala-Ala-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LGQPPBQRUBVTIF-JBDRJPRFSA-N 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- ZDILXFDENZVOTL-BPNCWPANSA-N Ala-Val-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZDILXFDENZVOTL-BPNCWPANSA-N 0.000 description 1
- OHYQKYUTLIPFOX-ZPFDUUQYSA-N Arg-Glu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OHYQKYUTLIPFOX-ZPFDUUQYSA-N 0.000 description 1
- UZSQXCMNUPKLCC-FJXKBIBVSA-N Arg-Thr-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UZSQXCMNUPKLCC-FJXKBIBVSA-N 0.000 description 1
- AWXDRZJQCVHCIT-DCAQKATOSA-N Asn-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O AWXDRZJQCVHCIT-DCAQKATOSA-N 0.000 description 1
- JBDLMLZNDRLDIX-HJGDQZAQSA-N Asn-Thr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O JBDLMLZNDRLDIX-HJGDQZAQSA-N 0.000 description 1
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 1
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 1
- MJJIHRWNWSQTOI-VEVYYDQMSA-N Asp-Thr-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O MJJIHRWNWSQTOI-VEVYYDQMSA-N 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 101710151559 Crystal protein Proteins 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- OYTPNWYZORARHL-XHNCKOQMSA-N Gln-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N OYTPNWYZORARHL-XHNCKOQMSA-N 0.000 description 1
- INGJLBQKTRJLFO-UKJIMTQDSA-N Glu-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O INGJLBQKTRJLFO-UKJIMTQDSA-N 0.000 description 1
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 1
- CQMFNTVQVLQRLT-JHEQGTHGSA-N Gly-Thr-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O CQMFNTVQVLQRLT-JHEQGTHGSA-N 0.000 description 1
- GYAFMRQGWHXMII-IUKAMOBKSA-N Ile-Asp-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N GYAFMRQGWHXMII-IUKAMOBKSA-N 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- DRCILAJNUJKAHC-SRVKXCTJSA-N Lys-Glu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DRCILAJNUJKAHC-SRVKXCTJSA-N 0.000 description 1
- PWPBGAJJYJJVPI-PJODQICGSA-N Met-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 PWPBGAJJYJJVPI-PJODQICGSA-N 0.000 description 1
- GHQFLTYXGUETFD-UFYCRDLUSA-N Met-Tyr-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N GHQFLTYXGUETFD-UFYCRDLUSA-N 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- XWBJLKDCHJVKAK-KKUMJFAQSA-N Phe-Arg-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N XWBJLKDCHJVKAK-KKUMJFAQSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- SXMSEHDMNIUTSP-DCAQKATOSA-N Pro-Lys-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SXMSEHDMNIUTSP-DCAQKATOSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- GFDUZZACIWNMPE-KZVJFYERSA-N Thr-Ala-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O GFDUZZACIWNMPE-KZVJFYERSA-N 0.000 description 1
- DKDHTRVDOUZZTP-IFFSRLJSSA-N Thr-Gln-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O DKDHTRVDOUZZTP-IFFSRLJSSA-N 0.000 description 1
- JKGGPMOUIAAJAA-YEPSODPASA-N Thr-Gly-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O JKGGPMOUIAAJAA-YEPSODPASA-N 0.000 description 1
- IJVNLNRVDUTWDD-MEYUZBJRSA-N Thr-Leu-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IJVNLNRVDUTWDD-MEYUZBJRSA-N 0.000 description 1
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 1
- SLOYNOMYOAOUCX-BVSLBCMMSA-N Trp-Phe-Arg Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SLOYNOMYOAOUCX-BVSLBCMMSA-N 0.000 description 1
- SBLZVFCEOCWRLS-BPNCWPANSA-N Tyr-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=C(C=C1)O)N SBLZVFCEOCWRLS-BPNCWPANSA-N 0.000 description 1
- ANHVRCNNGJMJNG-BZSNNMDCSA-N Tyr-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)O)N)O ANHVRCNNGJMJNG-BZSNNMDCSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/32—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Bacillus (G)
- G01N2333/325—Bacillus thuringiensis crystal protein (delta-endotoxin)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明公开了一种抗Cry3Bb蛋白单域重链抗体及其应用,属于基因工程抗体和食品生物技术领域。该单域重链抗体的氨基酸序列如SEQ ID NO.1所示,编码该氨基酸的核苷酸序列如SEQ ID NO.9所述,本发明提供的单域重链抗体可以有效结合Cry3Bb蛋白,可应用于Cry3Bb的免疫学检测,该单域重链抗体具有结合活性高、制备简单、稳定性好等特点。
Description
技术领域
本发明属于基因工程抗体和食品生物技术领域,具体涉及一种抗Cry3Bb蛋白单域重链抗体及其应用。
背景技术
Cry蛋白(crystal protein)是一类杀虫蛋白,对鳞翅目、双翅目、鞘翅目等多种昆虫具有高效毒杀作用,被广泛用作生物杀虫剂和转基因杀虫成分,常见的Cry蛋白包括Cry1Ab、Cry1Ac、Cry1C、Cry2A和Cry3Bb等。不同种类的Cry蛋白杀虫谱不同,Cry3Bb主要对鞘翅目昆虫如马铃薯甲虫有毒力。近年来,转基因农作物的种植面积呈快速增长趋势,但转基因农作物的安全性并未得到广泛认同,转基因农作物可能对生态环境和人体健康造成潜在危害。为安全起见,许多国家已经对转基因产品实行了标签制度。因此,对转基因农作物及其产品中的Cry蛋白进行有效监控和快速检测是十分必要的。
Cry蛋白的检测方法主要是基于核酸和蛋白质水平的分析,包括PCR方法和ELISA方法。PCR方法具有灵敏度高、准确性高等特点,但不能对表达的Cry蛋白进行定量检测,且需要专业的仪器设备和操作人员。而ELISA方法具有简便、快速、低耗等特点,适合于农作物和环境中Cry蛋白的现场快速定性和定量检测。其中,高特异性、高亲和性抗体的制备是ELISA方法建立的前提和关键。
单域重链抗体(VHH),源于驼科动物(骆驼、羊驼等)体内缺失轻链的重链抗体,是目前已知最小的功能性抗体片段,只含有3个互补决定区(Complementarity-determiningregion,CDR),却具有与普通抗体相同的抗体功能。与普通抗体相比,单域重链抗体的CDR3更长,可以形成凸环结构,能够伸入目标蛋白的凹槽、裂缝等普通抗体难以达到的表位。同时,单域重链抗体还具有高亲和力、高水溶性、易表达等特点。因此,单域重链抗体是一种优良的抗体材料;然而到目前为止,暂未见抗Cry3Bb蛋白单域重链抗体的报道。
发明内容
本发明的目的是通过噬菌体展示单域重链抗体库筛选,获得针对Cry3Bb蛋白的单域重链抗体。
本发明提供了一种抗Cry3Bb蛋白单域重链抗体,其氨基酸序列如SEQ ID NO.1所示。
本发明所提及的单域重链抗体包括四个框架区FR和三个互补决定区CDR。其中,框架区(FR1-FR4)的氨基酸序列分别如SEQ ID NO.2、SEQ ID NO.4、SEQ ID NO.6和SEQ IDNO.8所示;互补决定区(CDR1-CDR3)的氨基酸序列分别如SEQ ID NO.3、SEQ ID NO.5和SEQID NO.7所示。
本发明同时提供了编码氨基酸序列如SEQ ID NO.1所示抗Cry3Bb单域重链抗体的核苷酸,其序列如SEQ ID NO.9所示。
本发明还提供了一种重组表达载体,其含有如SEQ ID NO.9所示的核苷酸序列。
本发明还提供了一种重组工程菌,其含有所述重组表达载体。
本发明还提供了氨基酸序列如SEQ ID NO.1所示的单域重链抗体在Cry3Bb蛋白检测中的应用。
与现有技术相比,本发明的有益效果在于:
本发明制备的单域重链抗体可替代传统抗体,应用于Cry3Bb蛋白的免疫学检测分析,该单域重链抗体具有结合活性性高、稳定性高、易规模化制备等特点。
附图说明
图1单域重链抗体的氨基酸序列示意图;
图2单域重链抗体与Cry3Bb蛋白的分子对接示意图;
图3单域重链抗体结合活性测定结果示意图。
具体实施方式
下面结合具体实施方式对本发明做进一步阐述和说明。本发明中各个实施方式的技术特征在没有相互冲突的前提下,均可进行相应组合。
实施例1抗Cry3Bb单域重链抗体的淘选
将Cry3Bb蛋白用10mM PBS(pH 7.4)稀释至100μg/mL,加入酶标板,100μL/孔,4℃包被过夜;用PBST(10mM PBS,pH 7.4,含0.1%Tween-20)洗涤6次,加入300μL的3%BSA-PBS(3%OVA-PBS),37℃封闭2h;PBST洗板6次,加入100μL的噬菌体展示天然单域重链抗体库(滴度约2.0×1011pfu),37℃孵育1h;PBST洗涤6次,加入100μL的Glycine-HCl(0.2M,pH2.2)洗脱8min后,立即加入15μL Tris-HCl(1M,pH 9.0)中和,取10μL洗脱噬菌体测滴度,其余的感染处于对数生长期的大肠杆菌TG1进行扩增,扩增噬菌体经PEG/NaCl纯化后用于下一轮的淘选。
随后重复进行3轮淘选,淘选步骤与第一轮基本相同,包被的Cry3Bb蛋白的浓度分别减少为50μg/mL,25μg/mL和10μg/mL,PBST的洗涤次数分别增加为9次,12次和15次。
实施例2抗Cry3Bb单域重链抗体阳性噬菌体克隆的鉴定
从上述实施例1中第三轮和第四轮噬菌体滴度平板上随机挑取48个克隆,接种于2×YT-A培养基,37℃振荡培养过夜;按1%接种量(v/v)接种于1mL 2×YT-AG培养基,37℃振荡培养至OD600约为0.5;加入辅助噬菌体M13K07,37℃振荡培养45min;将培养物3000rpm离心10min后,加入1mL 2×YT-AK培养基重悬菌体,30℃200rpm振荡培养4-5h;将培养物于4℃下10000rpm离心10min,收集噬菌体上清,采用phage-ELISA进行阳性噬菌体克隆的鉴定。
具体方法为:将Cry3Bb蛋白用10mM PBS稀释至5μg/mL,加入酶标板,100μL/孔,4℃包被过夜;PBST洗板3次,加入300μL的5%脱脂奶粉,37℃封闭2h;PBST洗板3次,加入100μL噬菌体,37℃孵育1h;PBST洗板6次,加入100μL的HRP标记M13二抗(1:5000稀释),37℃孵育1h;PBST洗板6次,加入100μL TMB底物溶液,显色10min,在450nm波长处读取吸收值。当样品孔OD值大于对照孔OD值3倍以上时,初步判定为阳性克隆。将阳性噬菌体克隆送生物公司进行测序,获得核苷酸序列如SEQ ID NO.9所示。根据核苷酸测序结果及密码子表可翻译获得Cry3Bb单域重链抗体的氨基酸序列如图1所示。
实施例3抗Cry3Bb单域重链抗体的同源建模及与Cry3Bb蛋白的分子对接
将实施例2中的抗Cry3Bb单域重链抗体氨基酸序列提交SWISS-MODEL网站(网址为http://swissmodel.expasy.org/)进行同源建模,获得其三维结构模型;从NCBI数据库下载Cry3Bb蛋白的三维结构模型;随后利用ZDOCK网站(网址为http://zdock.umassmed.edu/)进行两个模型的分子对接,获得抗Cry3Bb单域重链抗体与Cry3Bb蛋白的复合物结构模型。三维结构模型采用PyMOL软件进行分析,抗Cry3Bb单域重链抗体(VHH)与Cry3Bb蛋白分子对接分析结果见图2,结果初步表明抗Cry3Bb单域重链抗体能够与Cry3Bb蛋白结合。
实施例4噬菌体展示单域重链抗体的扩增及活性鉴定
(1)噬菌体展示单域重链抗体的扩增
将实施例2获得的阳性噬菌体克隆细胞接种于50mL 2×YT-AG培养基中,37℃振荡培养至OD600约为0.5;加入辅助噬菌体M13K07,37℃振荡培养45min;将培养物10000rpm离心10min后,加入50mL 2×YT-AK培养基重悬菌体,30℃200rpm振荡培养过夜;将培养物于4℃下10000rpm离心10min,收集上清,加入1/6体积的PEG/NaCl,混匀后4℃静置4h;4℃下10000rpm离心10min,弃上清,将沉淀重悬于0.5mL PBS(10mM,pH 7.4)中,再加入0.5mL甘油,即得到扩增后的噬菌体展示单域重链抗体,-80℃保存备用。
(2)噬菌体展示单域重链抗体结合活性的鉴定
将Cry3Bb蛋白稀释至1μg/mL,加入酶标板,100μL/孔,4℃包被过夜;PBST洗板3次,加入300μL的5%BSA,37℃封闭2h;PBST洗板3次,加入100μL倍比稀释的上述噬菌体展示单域重链抗体(1:1000、1:2000、1:4000、1:8000、1:16000、1:32000、1:64000),37℃孵育1h;PBST洗板6次,加入100μL的HRP标记M13二抗(1:5000稀释),37℃孵育1h;PBST洗板6次,加入100μLTMB底物溶液,显色10min,在450nm波长处读取吸收值。选择吸收值在1.0-1.5之间的稀释倍数为扩增噬菌体展示单域重链抗体的最适稀释倍数。
将Cry3Bb蛋白倍比稀释(1000ng/mL、500g/mL、250ng/mL、125ng/mL、62.5ng/mL、31.25ng/mL、15.63ng/mL)后加入酶标板,100μL/孔,4℃包被过夜;PBST洗板3次,加入300μL的5%BSA,37℃封闭2h;PBST洗板3次,加入100μL上述最适稀释倍数的噬菌体展示单域重链抗体,37℃孵育1h;PBST洗板6次,加入100μL的HRP标记M13二抗(1:5000稀释),37℃孵育1h;PBST洗板6次,加入100μL TMB底物溶液,显色10min,在450nm波长处读取吸收值,结果如图3所示。从图中可见,噬菌体展示单域重链抗体能够结合Cry3Bb蛋白,活性测定曲线在15.63ng/mL-1000ng/mL范围内具有较好的线性。
实施例5抗Cry3Bb单域重链抗体在大肠杆菌中的表达及纯化
将实施例2中阳性噬菌体克隆携带的单域重链抗体基因亚克隆至表达载体pET-25b中,再将重组表达载体转化至肠杆菌Rosetta感受态细胞中,将细胞培养后涂布于LB-A平板,37℃培养过夜;从平板上挑取单菌落接种于5mL LB培养基中,37℃,200rpm振荡培养过夜,将过夜培养物按1%接种量(v/v)接种于50mL的LB-AG培养基中,37℃,200rpm振荡培养;当培养物菌体浓度OD600达到0.5时,向培养物中加入终浓度为0.1mM的IPTG,30℃,200rpm振荡培养过夜;将培养物于4℃,8000rpm离心15min收集菌体沉淀;重悬细胞于5mL预冷的PBS溶液,超声破碎10min后,8000rpm离心15min取上清,即得单域重链抗体粗提液;将上清经镍柱进行纯化,得到纯度90%以上的单域重链抗体蛋白。
实施例6单域重链抗体在Cry3Bb免疫检测中的应用
(1)标准曲线的建立
将抗Cry3Bb单克隆抗体稀释至1μg/mL,4℃包被过夜;PBST洗涤3次,加入300μL的5%BSA,37℃封闭2h;PBST洗板3次,加入100μL不同浓度的Cry3Bb蛋白标准品,37℃孵育1h;PBST洗板6次,加入实施例3获得的噬菌体展示单域重链抗体/实施例4获得的单域重链抗体蛋白,37℃孵育1h;PBST洗板6次,加入HRP标记的抗M13二抗/抗His标签二抗,37℃孵育1h;PBST洗板6次,加入100μL TMB底物溶液,显色15min,在450nm波长处读取吸收值,建立ELISA标准曲线。
(2)样品的检测
称取1g待检样品(市售玉米),粉碎后加入5mL PBS溶液,充分振荡1h;10000rpm离心10min后,取上清液用滤纸进行过滤,取1mL滤液与1mL PBS混匀,即为样品提取液。用样品提取液替代上述Cry3Bb蛋白标准品,按照标准曲线方法进行操作,根据标准曲线推算出样品中Cry3Bb的含量。
序列表
<110> 中国计量大学
<120> 一种抗Cry3Bb蛋白单域重链抗体及其应用
<160> 9
<170> SIPOSequenceListing 1.0
<210> 1
<211> 119
<212> PRT
<213> Lama pacos
<400> 1
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Ser Val Ala Thr Gly Gly
1 5 10 15
Ser Leu Lys Leu Ser Cys Leu Ala Arg Gly Arg Asp Arg Arg Thr Asn
20 25 30
Tyr Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Ile Val
35 40 45
Ala Ala Ile Asp Thr Arg Thr Gly Val Ala Val Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Pro Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Lys Thr Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys Gly Arg Thr Tyr Asp Arg Ser Trp Lys Pro Leu Gly Gln Gly
100 105 110
Thr Gln Val Thr Val Ser Ser
115
<210> 2
<211> 25
<212> PRT
<213> Lama pacos
<400> 2
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Ser Val Ala Thr Gly Gly
1 5 10 15
Ser Leu Lys Leu Ser Cys Leu Ala Arg
20 25
<210> 3
<211> 8
<212> PRT
<213> Lama pacos
<400> 3
Gly Arg Asp Arg Arg Thr Asn Tyr
1 5
<210> 4
<211> 17
<212> PRT
<213> Lama pacos
<400> 4
Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Ile Val Ala
1 5 10 15
Ala
<210> 5
<211> 8
<212> PRT
<213> Lama pacos
<400> 5
Ile Asp Thr Arg Thr Gly Val Ala
1 5
<210> 6
<211> 38
<212> PRT
<213> Lama pacos
<400> 6
Val Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn
1 5 10 15
Pro Lys Asn Thr Leu Tyr Leu Gln Leu Asn Ser Leu Lys Thr Glu Asp
20 25 30
Thr Ala Met Tyr Tyr Cys
35
<210> 7
<211> 12
<212> PRT
<213> Lama pacos
<400> 7
Ala Lys Gly Arg Thr Tyr Asp Arg Ser Trp Lys Pro
1 5 10
<210> 8
<211> 11
<212> PRT
<213> Lama pacos
<400> 8
Leu Gly Gln Gly Thr Gln Val Thr Val Ser Ser
1 5 10
<210> 9
<211> 357
<212> DNA
<213> Lama pacos
<400> 9
caggtgcagc tgcaggagtc tggaggaggc tcggtggcca ctggagggtc tctgaaactc 60
tcctgtctag cccgtggaag ggaccgtcgt accaactaca tggcctggtt ccgccaggct 120
ccagggaagg agcgcgaaat agtcgcggca attgacacgc gtactggtgt cgcagtctat 180
gccgactccg tgaagggccg attcaccatc tccagagaca accccaagaa cacgctgtat 240
ctgcaattga acagcctgaa aactgaggac acggccatgt attactgtgc aaaaggccgg 300
acttacgatc gtagctggaa acccctgggc caggggaccc aggtcaccgt ctcctca 357
Claims (4)
1. 一种抗Cry3Bb单域重链抗体,其特征在于,其氨基酸序列如SEQ ID NO.1所示。
2. 一种编码如权利要求1所述单域重链抗体的核酸,其核苷酸序列如SEQ ID NO.9所示。
3.一种重组表达载体,其含有如SEQ ID NO.9所示的核苷酸序列。
4.一种重组工程菌,其含有权利要求3所述重组表达载体。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111086088.XA CN113754762B (zh) | 2021-09-16 | 2021-09-16 | 一种抗Cry3Bb蛋白单域重链抗体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111086088.XA CN113754762B (zh) | 2021-09-16 | 2021-09-16 | 一种抗Cry3Bb蛋白单域重链抗体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113754762A CN113754762A (zh) | 2021-12-07 |
CN113754762B true CN113754762B (zh) | 2023-04-11 |
Family
ID=78795943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111086088.XA Active CN113754762B (zh) | 2021-09-16 | 2021-09-16 | 一种抗Cry3Bb蛋白单域重链抗体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113754762B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114371295B (zh) * | 2021-12-28 | 2024-06-11 | 中国农业科学院生物技术研究所 | 定量检测抗虫蛋白Cry 3Bb的酶联免疫试剂盒及其检测方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108101970B (zh) * | 2017-12-14 | 2021-02-26 | 江苏省农业科学院 | 基于抗独特型纳米抗体的Cry1Ab毒素模拟抗原及其应用 |
CN109762065B (zh) * | 2019-01-25 | 2022-12-06 | 南昌大学 | 针对河流弧菌的单域重链抗体Nb72 |
CN110317242B (zh) * | 2019-06-12 | 2021-03-26 | 南昌大学 | 可特异性结合Cry1Da蛋白的多肽分子及其应用 |
CN110317241B (zh) * | 2019-06-12 | 2022-09-16 | 南昌大学 | 抗Cry1Da蛋白的多肽分子及其应用 |
-
2021
- 2021-09-16 CN CN202111086088.XA patent/CN113754762B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN113754762A (zh) | 2021-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shu et al. | Anti-idiotypic nanobody: A strategy for development of sensitive and green immunoassay for Fumonisin B1 | |
CN108101970B (zh) | 基于抗独特型纳米抗体的Cry1Ab毒素模拟抗原及其应用 | |
CN104592389B (zh) | 抗脱氧雪腐镰刀菌烯醇抗体的纳米抗体 | |
CN105218676B (zh) | 玉米赤霉烯酮抗独特型纳米抗体及其应用 | |
CN108794632B (zh) | 一种广谱特异性识别二乙氧基有机磷农药的纳米抗体及酶联免疫分析方法 | |
Xu et al. | Construction of an immunized rabbit phage display antibody library for screening microcystin-LR high sensitive single-chain antibody | |
CN111269318B (zh) | 一种gapdh纳米抗体及其应用 | |
CN106749527A (zh) | 氯噻啉抗体特异性结合的噬菌体展示多肽及其用途 | |
Xu et al. | Establishment of a sensitive time-resolved fluoroimmunoassay for detection of Bacillus thuringiensis Cry1Ie toxin based nanobody from a phage display library | |
Xu et al. | Microcystin-LR heterologous genetically engineered antibody recombinant and its binding activity improvement and application in immunoassay | |
CN114106166A (zh) | 人源抗新冠病毒中和性抗体d2及其应用 | |
CN113754762B (zh) | 一种抗Cry3Bb蛋白单域重链抗体及其应用 | |
Xu et al. | High sensitive single chain variable fragment screening from a microcystin-LR immunized mouse phage antibody library and its application in immunoassay | |
CN104926940B (zh) | 一种人源杀虫蛋白及其制备方法与应用 | |
CN111303292B (zh) | 一种特异性识别百草枯的纳米抗体Nb2-37及其应用 | |
Hoseinpoor et al. | Functional mutations in and characterization of VHH against Helicobacter pylori urease | |
Xu et al. | Selection and application of broad-specificity human domain antibody for simultaneous detection of Bt Cry toxins | |
CN113637071B (zh) | 一种针对Cry3Bb蛋白的纳米抗体及其制备和用途 | |
CN105218675B (zh) | 可特异性结合抗玉米赤霉烯酮抗体的纳米抗体及其应用 | |
CN104311643B (zh) | 基于纳米抗体的脱氧雪腐镰刀菌烯醇模拟抗原及其应用 | |
CN114702592B (zh) | 一种识别喹硫磷农药的纳米抗体及酶联免疫分析方法 | |
CN105884892B (zh) | 一种Bt Cry毒素广谱检测用蛋白及其编码基因与应用 | |
CN107056946A (zh) | 一种抗二乙氧基硫代磷酸酯类有机磷农药的Fab抗体及制备方法和应用 | |
CN110407943A (zh) | 一种克百威农药的纳米抗体及其制备方法和应用 | |
CN112794910B (zh) | 一种抗pd-1的纳米抗体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |